Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholics
- PMID: 2721103
- DOI: 10.1038/clpt.1989.61
Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholics
Abstract
The influence of disulfiram on theophylline metabolism was studied in 20 recovering alcoholics. Ten of the patients, who were selected at random, received 250 mg of disulfiram daily. The other 10 patients received 500 mg of disulfiram daily. Two single-dose studies of theophylline kinetics were performed--one as a baseline control and the other after 1 week of treatment with disulfiram. With disulfiram pretreatment, the plasma clearance of theophylline was decreased from 105.7 +/- 10.2 (mean +/- SEM) to 83.1 +/- 8.1 ml/kg per hour (p less than 0.001) in the 250 mg group and from 94.3 +/- 13.3 to 65.4 +/- 10.7 ml/mg per hour (p less than 0.001) in the 500 mg group. The elimination half-life was prolonged significantly in both groups. The percent reduction in theophylline clearance was greater in the 500 mg group (32.5 +/- 3.1; range, 21.6 to 49.6) than it was in the 250 mg group (21.2 +/- 1.7; range, 14.6 to 29.6; p less than 0.01). Disulfiram decreased the formation of all theophylline metabolites in smokers in both treatment groups. In each group, the hydroxylation pathway was affected more than the demethylation pathway. These data indicate that at therapeutic doses disulfiram exerts a dose-dependent inhibitory effect on theophylline metabolism. Depending on the dose of disulfiram, a dose reduction of theophylline by as much as 50% may be necessary to minimize the risk of toxicity.
Similar articles
-
Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics.Clin Pharmacol Ther. 1986 Mar;39(3):265-70. doi: 10.1038/clpt.1986.37. Clin Pharmacol Ther. 1986. PMID: 3948467
-
Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokers.Clin Pharmacol Ther. 1991 May;49(5):571-80. doi: 10.1038/clpt.1991.67. Clin Pharmacol Ther. 1991. PMID: 2029830 Clinical Trial.
-
Pharmacokinetic interaction of disulfiram and antidepressants.Am J Psychiatry. 1985 Nov;142(11):1373-4. doi: 10.1176/ajp.142.11.1373. Am J Psychiatry. 1985. PMID: 4061700
-
[Pharmacology of disulfiram - an update].Fortschr Neurol Psychiatr. 2008 Apr;76(4):225-31. doi: 10.1055/s-2007-1016438. Fortschr Neurol Psychiatr. 2008. PMID: 18415930 Review. German.
-
Guide to therapy with theophylline for the treatment of obstructive lung disease.J Int Med Res. 1988 Jan-Feb;16(1):1-18. doi: 10.1177/030006058801600101. J Int Med Res. 1988. PMID: 3280361 Review.
Cited by
-
Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.Clin Pharmacokinet. 1995 Apr;28(4):287-314. doi: 10.2165/00003088-199528040-00003. Clin Pharmacokinet. 1995. PMID: 7648758 Review.
-
Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.Br J Clin Pharmacol. 2002 Feb;53(2):155-62. doi: 10.1046/j.1365-2125.2002.01522.x. Br J Clin Pharmacol. 2002. PMID: 11851639 Free PMC article.
-
The effects of nitrogen-heme-iron coordination on substrate affinities for cytochrome P450 2E1.Chem Biol Interact. 2011 Aug 15;193(1):50-6. doi: 10.1016/j.cbi.2011.05.001. Epub 2011 May 10. Chem Biol Interact. 2011. PMID: 21600194 Free PMC article.
-
Drug interactions with St John's wort : mechanisms and clinical implications.Drug Saf. 2004;27(11):773-97. doi: 10.2165/00002018-200427110-00003. Drug Saf. 2004. PMID: 15350151 Review.
-
Inhibition of Urease by Disulfiram, an FDA-Approved Thiol Reagent Used in Humans.Molecules. 2016 Nov 26;21(12):1628. doi: 10.3390/molecules21121628. Molecules. 2016. PMID: 27898047 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical